申请人:RECORDATI S.A.
CHEMICAL and PHARMACEUTICAL COMPANY
公开号:EP0076600A1
公开(公告)日:1983-04-13
Anthranilic acid esters I
have analgesic and anti-inflammatory properties. They are prepared by condensing a salt (preferably Na) of an N-(7- or 8-substituted-4-quinolyl)-anthranilic acid with a haloderiva- tive Halo-(CH2)n-R. The condensation conditions are suitably equimolar proportion, 30 to 150°C, DMF as solvent. Pharmaceutical preparations are also disclosed.
蒽酸酯 I 具有镇痛和消炎作用,其制备方法是将 N-(7-或 8-取代的-4-喹啉基)-蒽酸的盐(最好是 Na)与卤代-(CH2)n-R 缩合。 缩合条件为适当的等摩尔比例、30 至 150°C、DMF 作为溶剂。 还公开了药物制剂。